NCT01750684View on ClinicalTrials.gov

AC105 in Patients With Acute Traumatic Spinal Cord Injury

PHASE2TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

May 31, 2015

Conditions
Acute Spinal Cord Injury
Interventions
DRUG

AC105

OTHER

Placebo

Sponsors

Collaborators (1)

DP Clinical, Inc.
All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

DP Clinical, Inc.

INDUSTRY

lead

Acorda Therapeutics

INDUSTRY

NCT01750684 - AC105 in Patients With Acute Traumatic Spinal Cord Injury | Biotech Hunter | Biotech Hunter